Identification of Metabolic Biomarkers in Bone Marrow Aspirate for Diagnosis, Prognosis, and Therapeutic Monitoring in Pediatric Langerhans Cell Histiocytosis

Key Points

• The research aims to discover metabolic biomarkers in bone marrow aspirate for diagnosing and monitoring LCH.
• Analyzed metabolic profiles in bone marrow aspirate samples from LCH patients
• Identified specific metabolites linked to LCH
• Evaluated metabolites for their diagnostic and prognostic capacities
• Specific metabolic alterations were identified in LCH patients
• Certain metabolites indicated potential for diagnosis and prognosis
• Findings suggest metabolites could assist in therapeutic monitoring